查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1611209

CRISPR 和 Cas 基因市場規模、佔有率和趨勢分析報告：按產品/服務、應用、最終用途、地區和細分市場預測，2025-2030 年

CRISPR And Cas Genes Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents, Cell Line Engineering), By Application (Biomedical, Agricultural), By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

CRISPR 和 Cas 基因市場成長和趨勢

Grand View Research, Inc.最新報告顯示，到2030年，全球CRISPR和Cas基因市場規模預計將達到113.3億美元，2025年至2030年複合年成長率為16.12%。由於基因組編輯片段的發展，CRISPR-Cas系統在原核診斷和演化分析評估中的使用顯著增加。該技術的應用使得輕鬆且低成本地編輯基因成為可能。基因組編輯在生物醫學研究方面取得了長足的進步，當前的最尖端科技趨勢正在為未來治療多種遺傳和非遺傳疾病鋪平道路。

CRISPR/Cas9介導的基因和基因組編輯技術的出現促進了更有效的基因標靶方法的開發和實施以及基因編輯鳥類的創造。根據 2021 年 2 月發表在 Frontiers 上的一篇論文，CRISPR/Cas9 已成為家禽業基因編輯的強大且重要的工具。預計多個領域的潛在應用將進一步推動對該技術的需求。 COVID-19 的爆發已將研究人員的注意力轉移到利用該技術開發 COVID-19 分子診斷工具。例如，2021 年 3 月，新加坡南洋理工大學的研究人員創建了基於 CRISPR 的 COVID-19 測試，可以在 30 分鐘內提供結果。

即使病毒發生變異，此測試也能偵測到該病毒。這將進一步鼓勵其他主要企業利用這項技術，進一步促進產業成長。這項技術擴大用於醫療和其他應用。隨著越來越多的學術機構和生物技術公司尋求為該技術開發新的商業性應用，這些基因編輯技術的專利競爭預計將加劇。此外，透過使用機器學習技術來推進這項技術具有巨大的潛力。例如，2022 年 8 月，Synthego 推出了工程細胞庫，這是一項尖端服務，透過排列 CRISPR 編輯的細胞以直接用於我所做的功能篩檢實驗，從而擴大了 CRISPR 的使用範圍。

有望應用於疾病研究。主要企業為基因編輯工作流程的每個步驟提供工具和解決方案。透過整合多種工具、服務和改進的流程，您可以更快、更輕鬆地完成研究實驗。此外，主要企業也籌集了大量資金來支持 CRISPR 和 Cas9 基因編輯方法的研究和開發。例如，2021年4月，Vertex Pharmaceuticals與CRISPR Therapeutics合作開發和製造一種基於CRISPR/Cas9的新型基因編輯療法，名為CTX001，該療法可能成為輸血依賴性BETA地中海貧血和鐮狀細胞疾病（SCD）的治療選擇我做到了。 2020 年 1 月，Mammoth Biosciences 籌集了 4,500 萬美元，用於開發用於治療和診斷目的的下一代 CRISPR 產品。這將進一步用於開發該公司的 CRISPR 基因主導診斷產品組合。

CRISPR 和 Cas 基因市場報告亮點

  • 從產品和服務來看，2024年產品細分市場佔據產業主導地位，佔比最高，達77.39%。
  • 到2024年，生物醫藥領域將主導該產業。廣泛的研究和利用基因組編輯先進技術的研究數量的顯著增加正在促進這一領域的成長。
  • 2024年，生技和製藥公司佔據市場主導地位，佔整體收益佔有率的49.56%。主要企業正在利用這項技術創建人類疾病的生物模型，並進一步加速新治療標靶的識別。
  • 北美市場佔據主導地位，2024 年收益佔有率最高，達 41.36%。這是由於多個製藥巨頭的存在、研究經費的增加、更多的研究核准以及對新療法的需求。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 工業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第4章產品/服務業務分析

  • 產品/服務細分儀表板
  • 全球 CRISPR 和 CAS 基因市場：產品/服務波動分析
  • 2018-2030 年全球 CRISPR 和 CAS 基因市場規模和趨勢分析（按產品/服務）
  • 產品
    • 產品市場，2018-2030
    • 試劑套件和試劑
    • 圖書館
    • 設計工具
    • 抗體
    • 其他
  • 服務
    • 服務市場，2018-2030
    • 細胞株工程
    • gRNA設計與合成
    • 篩檢服務
    • 其他

第5章 應用業務分析

  • 使用細分儀表板
  • 全球CRISPR和CAS基因市場：應用變異分析
  • 2018-2030 年全球 CRISPR 與 CAS 基因市場規模及趨勢分析（按應用）
  • 生物醫學
    • 生物醫藥市場，2018-2030
    • 基因組工程
    • 疾病模型研究
    • 功能基因體學
    • 表觀遺傳學
    • 其他
  • 農業
    • 農產品市場，2018-2030

第6章 最終用途業務分析

  • 最終用途細分儀表板
  • 全球 CRISPR 和 CAS 基因市場：最終用途變異分析
  • 2018-2030 年全球 CRISPR 和 CAS 基因市場規模和趨勢分析（按最終用途）
  • 生物技術和製藥公司
    • 生物技術和製藥市場，2018-2030
  • 學術/政府研究院
    • 學術與政府研究市場，2018-2030
  • 合約研究組織（CRO）
    • 合約研究組織 (CRO) 市場，2018-2030
  • 其他
    • 其他市場，2018-2030

第7章 區域業務分析

  • 區域儀表板
  • 2018-2030年市場規模、預測與趨勢分析
  • 北美洲
    • 北美 CRISPR 和 CAS 基因市場，2018-2030
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲 CRISPR 和 CAS 基因市場，2018-2030
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太地區 CRISPR 和 CAS 基因市場，2018-2030
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 拉丁美洲 CRISPR 和 CAS 基因市場，2018-2030 年
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 中東和非洲 CRISPR 和 CAS 基因市場，2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 參與企業
  • 策略規劃
  • 2024 年企業市場分析
  • 公司簡介/上市公司
    • Thermo Fisher Scientific
    • Illumina
    • Agilent Technologies
    • Synthego
    • Danaher
    • Origene Technologies
    • GenScript
    • Lonza
    • Revvity, Inc.
    • Merck KGaA
Product Code: GVR-1-68038-375-1

CRISPR And Cas Genes Market Growth & Trends:

The global CRISPR and Cas genes market size is expected to reach USD 11.33 billion by 2030, growing at a CAGR of 16.12% from 2025 to 2030, according to a new report by Grand View Research, Inc. The use of CRISPR-Cas systems in diagnostics and the assessment of evolutionary analysis in prokaryotes has significantly increased, owing to the developments in the field of genome editing. The application of this technology enables easy and cost-efficient editing of genes. Genome editing has made a significant advancement in biomedical research, with the present trend of cutting-edge techniques paving the way for the future treatment of different genetic and non-genetic disorders.

The development and implementation of more effective ways for gene targeting and the generation of gene-edited avian species have been facilitated by the availability of the CRISPR/Cas9-mediated gene and genome editing technology. According to an article published on Frontiers in February 2021, CRISPR/Cas9 has become a robust and important tool for gene editing in the poultry industry. Potential applications in several fields would further boost the demand for this technology. The COVID-19 outbreak shifted the researcher's emphasis to the development of COVID-19 molecular diagnostic tools based on this technology. For instance, in March 2021, Nanyang Technological University researchers in Singapore created a COVID-19 test based on CRISPR that provides results in 30 minutes.

Even after the virus has mutated, this test still discovers it. This would further encourage the other key players to leverage this technique, thereby driving the industry's growth. This technology is increasingly being used for several medical and other applications. Competition over patents for such a gene-editing technology is expected to grow, as more academic institutions and biotech companies attempt to develop new commercial applications of this technology. In addition, there is a lot of potential for this technique to advance with the use of machine learning technologies. For instance, in August 2022, Synthego launched engineered cell libraries, a cutting-edge service that expands access to CRISPR by giving arrayed CRISPR-edited cells for use directly in functional screening experiments.

It has potential applications in disease research. Key players offer tools and solutions for each step of the gene editing workflow. Integrating several tools, services, and improved processes makes it possible to complete research experiments rapidly and with little effort. Moreover, key players have raised significant funding to support the R&D of the CRISPR & Cas9 gene-editing approach. For instance, in April 2021, Vertex Pharmaceuticals collaborated with CRISPR Therapeutics to develop and manufacture a new CRISPR/Cas9-based gene editing therapy called CTX001, a potential therapeutic option for transfusion-dependent beta-thalassemia and Sickle Cell Disease (SCD). In January 2020, Mammoth Biosciences raised USD 45 million to develop next-gen CRISPR products for therapeutics & diagnostics purposes. This would further be used to develop the company's CRISPR genes-driven diagnostics portfolio.

CRISPR And Cas Genes Market Report Highlights:

  • By product and services, the product segment dominated the industry in 2024 and accounted for the highest share of 77.39%
  • The biomedical segment dominated the industry in 2024. Extensive research and a significant rise in the number of research studies utilizing the advanced technique for genome editing have contributed to the segment growth
  • The biotechnology and pharmaceutical companies dominated the market in 2024, accounting for 49.56% of overall revenue share. Key players are adopting this technology to produce biological models for human diseases and further accelerate new therapeutic target identification
  • North America dominated the market and accounted for the highest revenue share of 41.36% in 2024 owing to the presence of several pharmaceutical giants, increased research funding, a high number of research approvals, and the need for novel therapeutics

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service Segment
    • 1.2.2. Application Segment
    • 1.2.3. End Use Segment
  • 1.3. Information Analysis
    • 1.3.1. Market Formulation & Data Visualization
  • 1.4. Data Validation & Publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing Need For Novel Therapeutics
      • 3.2.1.2. Rising Demand For Gene Editing
      • 3.2.1.3. Rising Incidence Of Cancer
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Off-Target Effects Of CRISPR Technology
      • 3.2.2.2. High Cost Factor, Intellectual Property Disputes & Ethical Dilemma
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product & Service Business Analysis

  • 4.1. Product & Service Segment Dashboard
  • 4.2. Global CRISPR And CAS Genes Market: Product & Service Movement Analysis
  • 4.3. Global CRISPR And CAS Genes Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
  • 4.4. Products
    • 4.4.1. Products Market, 2018 - 2030 (USD Million)
    • 4.4.2. Kits & Reagents
      • 4.4.2.1. Kits & Reagents Market, 2018 - 2030 (USD Million)
      • 4.4.2.2. Cas Proteins & Enzymes
        • 4.4.2.2.1. Cas Proteins & Enzymes Market, 2018 - 2030 (USD Million)
      • 4.4.2.3. Guide RNA
        • 4.4.2.3.1. Guide RNA Market, 2018 - 2030 (USD Million)
      • 4.4.2.4. Others
        • 4.4.2.4.1. Others Market, 2018 - 2030 (USD Million)
    • 4.4.3. Libraries
      • 4.4.3.1. Libraries Market, 2018 - 2030 (USD Million)
    • 4.4.4. Design Tool
      • 4.4.4.1. Design Tool Market, 2018 - 2030 (USD Million)
    • 4.4.5. Antibodies
      • 4.4.5.1. Antibodies Market, 2018 - 2030 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Other Products Market, 2018 - 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services Market, 2018 - 2030 (USD Million)
    • 4.5.2. Cell Line Engineering
      • 4.5.2.1. Cell Line Engineering Market, 2018 - 2030 (USD Million)
    • 4.5.3. gRNA Design & Synthesis
      • 4.5.3.1. gRNA Design & Synthesis Market, 2018 - 2030 (USD Million)
    • 4.5.4. Screening Services
      • 4.5.4.1. Screening Services Market, 2018 - 2030 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global CRISPR And CAS Genes Market: Application Movement Analysis
  • 5.3. Global CRISPR And CAS Genes Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Biomedical
    • 5.4.1. Biomedical Market, 2018 - 2030 (USD Million)
    • 5.4.2. Genome Engineering
      • 5.4.2.1. Genome Engineering Market, 2018 - 2030 (USD Million)
    • 5.4.3. Disease Model Studies
      • 5.4.3.1. Disease Model Studies Market, 2018 - 2030 (USD Million)
    • 5.4.4. Functional Genomics
      • 5.4.4.1. Functional Genomics Market, 2018 - 2030 (USD Million)
    • 5.4.5. Epigenetics
      • 5.4.5.1. Epigenetics Market, 2018 - 2030 (USD Million)
    • 5.4.6. Others
      • 5.4.6.1. Other Biomedical Applications Market, 2018 - 2030 (USD Million)
  • 5.5. Agricultural
    • 5.5.1. Agricultural Market, 2018 - 2030 (USD Million)

Chapter 6. End Use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Global CRISPR And CAS Genes Market: End Use Movement Analysis
  • 6.3. Global CRISPR And CAS Genes Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Biotechnology & Pharmaceutical Companies
    • 6.4.1. Biotechnology & Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 6.5. Academic & Government Research Institutes
    • 6.5.1. Academic & Government Research Institutes Market, 2018 - 2030 (USD Million)
  • 6.6. Contract Research Organizations (CROs)
    • 6.6.1. Contract Research Organizations (CROs) Market, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. North America CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. U.S. CRISPR And CAS Genes Market, 2018 - 2030 (USD MILLION)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Canada CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Mexico CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Germany CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.4.3. UK
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. UK CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. France CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Italy CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Spain CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Denmark CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Sweden CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Norway CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Japan CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. China CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. India CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. South Korea CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Australia CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Thailand CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Brazil CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Argentina CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. South Africa CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Saudi Arabia CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. UAE CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Kuwait CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product/Service Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Illumina
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product/Service Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Agilent Technologies
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product/Service Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Synthego
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product/Service Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Danaher
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product/Service Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Origene Technologies
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product/Service Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. GenScript
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product/Service Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Lonza
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product/Service Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Revvity, Inc.
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product/Service Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Merck KGaA
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product/Service Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 3 Global CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 4 Global CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 5 Global CRISPR and Cas genes market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America CRISPR and Cas genes market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 8 North America CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 11 U.S. CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 14 Canada CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 17 Mexico CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe CRISPR and Cas genes market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 21 Europe CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Germany CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 24 Germany CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 25 Germany CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 26 UK CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 27 UK CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 30 France CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 31 France CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 33 Italy CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 36 Spain CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Denmark CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 39 Denmark CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 42 Sweden CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Norway CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 45 Norway CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 46 Norway CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific CRISPR and Cas genes market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 51 China CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 52 China CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 53 China CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Japan CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 55 Japan CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 56 Japan CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 58 India CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 59 India CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Australia CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 61 Australia CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 62 Australia CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Thailand CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 64 Thailand CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 65 Thailand CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 66 South Korea CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 67 South Korea CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 68 South Korea CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America CRISPR and Cas genes market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 71 Latin America CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 74 Brazil CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 77 Argentina CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Middle East and Africa CRISPR and Cas genes market, by country, 2018 - 2030 (USD Million)
  • Table 80 Middle East and Africa CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 81 Middle East and Africa CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 82 Middle East and Africa CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 83 South Africa CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 84 South Africa CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Africa CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 89 UAE CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 90 UAE CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 91 UAE CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 93 Kuwait CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 94 Kuwait CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 CRISPR and Cas genes market segmentation
  • Fig. 8 Market snapshot
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 PESTEL analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global CRISPR and Cas genes market: Product & service movement analysis
  • Fig. 15 Global CRISPR and Cas genes market, for product, 2018 - 2030 (USD Million)
  • Fig. 16 Global CRISPR and Cas genes market, for kits & enzymes, 2018 - 2030 (USD Million)
  • Fig. 17 Global CRISPR and Cas genes market, for Cas proteins & enzymes, 2018 - 2030 (USD Million)
  • Fig. 18 Global CRISPR and Cas genes market, for guide RNA, 2018 - 2030 (USD Million)
  • Fig. 19 Global CRISPR and Cas genes market, for others, 2018 - 2030 (USD Million)
  • Fig. 20 Global CRISPR and Cas genes market, for libraries, 2018 - 2030 (USD Million)
  • Fig. 21 Global CRISPR and Cas genes market, for design tool, 2018 - 2030 (USD Million)
  • Fig. 22 Global CRISPR and Cas genes market, for antibodies , 2018 - 2030 (USD Million)
  • Fig. 23 Global CRISPR and Cas genes market, for other products, 2018 - 2030 (USD Million)
  • Fig. 24 Global CRISPR and Cas genes market, for service, 2018 - 2030 (USD Million)
  • Fig. 25 Global CRISPR and Cas genes market, for cell line engineering , 2018 - 2030 (USD Million)
  • Fig. 26 Global CRISPR and Cas genes market, for gRNA design & synthesis, 2018 - 2030 (USD Million)
  • Fig. 27 Global CRISPR and Cas genes market, for screening services, 2018 - 2030 (USD Million)
  • Fig. 28 Global CRISPR and Cas genes market, for other services, 2018 - 2030 (USD Million)
  • Fig. 29 Global CRISPR and Cas genes market: Application movement analysis
  • Fig. 30 Global CRISPR and Cas genes market, for biomedical , 2018 - 2030 (USD Million)
  • Fig. 31 Global CRISPR and Cas genes market, for genome engineering, 2018 - 2030 (USD Million)
  • Fig. 32 Global CRISPR and Cas genes market, for disease model studies, 2018 - 2030 (USD Million)
  • Fig. 33 Global CRISPR and Cas genes market, for functional genomics, 2018 - 2030 (USD Million)
  • Fig. 34 Global CRISPR and Cas genes market, for epigenetics, 2018 - 2030 (USD Million)
  • Fig. 35 Global CRISPR and Cas genes market, for other biomedical applications, 2018 - 2030 (USD Million)
  • Fig. 36 Global CRISPR and Cas genes market, for agricultural , 2018 - 2030 (USD Million)
  • Fig. 37 Global CRISPR and Cas genes market: End Use movement analysis
  • Fig. 38 Global CRISPR and Cas genes market, for biotechnology & pharmaceutical companies, 2018 - 2030 (USD Million)
  • Fig. 39 Global CRISPR and Cas genes market, for academic & government research institutes, 2018 - 2030 (USD Million)
  • Fig. 40 Global CRISPR and Cas genes market, for Contract Research Organizations (CROs), 2018 - 2030 (USD Million)
  • Fig. 41 Global CRISPR and Cas genes market, for other end use, 2018 - 2030 (USD Million)
  • Fig. 42 Regional outlook, 2024 & 2030
  • Fig. 43 North America CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 45 Canada CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 46 Mexico CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 47 Europe CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 48 Germany CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 49 UK CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 50 France CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 51 Italy CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 52 Spain CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 53 Denmark CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 54 Sweden CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 55 Norway CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 57 Japan CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 58 China CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 59 India CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 60 Australia CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 61 Thailand CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 62 South Korea CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 63 Latin America CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 64 Brazil CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 65 Argentina CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 66 MEA CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 67 South Africa CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 68 Saudi Arabia CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 69 UAE CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 70 Kuwait CRISPR and Cas genes market, 2018 - 2030 (USD Million)